Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Omega Therapeutics, Inc.
  6. Financials
    OMGA   US68217N1054

OMEGA THERAPEUTICS, INC.

(OMGA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2021 2022 2023 2024
Capitalization1 541109--
Enterprise Value (EV)1 33645,4-242-69,2
P/E ratio -3,71x-1,05x-0,86x-0,89x
Yield ----
Capitalization / Revenue 3 759x307x--
EV / Revenue 2 332x128x--
EV / EBITDA -5,20x-0,51x1,90x0,35x
Price to Book ----
Nbr of stocks (in thousands) 47 77547 848--
Reference price (USD) 11,32,282,282,28
Announcement Date 03/10/2022---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2020 2021 2022 2023 2024
Net sales1 -0,140,36--
EBITDA1 --64,6-88,9-128-197
Operating profit (EBIT)1 --66,0-101-143-182
Operating Margin --45 856%-28 539%--
Pre-Tax Profit (EBT)1 --68,3-97,3-139-166
Net income1 -29,4-68,3-104-145-163
Net margin --47 417%-29 283%--
EPS2 -7,56-3,05-2,17-2,64-2,58
Dividend per Share -----
Announcement Date 07/09/202103/10/2022---
1 USD in Million
2 USD
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4
Net sales1 -0,140,270,050,050,05
EBITDA ------
Operating profit (EBIT)1 -17,2-20,7-20,0-24,7-27,1-29,8
Operating Margin --14 350%-7 447%-47 925%-52 557%-57 939%
Pre-Tax Profit (EBT)1 -18,5-20,9-20,2-22,9-25,6-28,7
Net income1 -18,5-20,9-20,2-25,6-28,1-30,2
Net margin --14 482%-7 524%-49 792%-54 633%-58 733%
EPS2 -0,57-0,44-0,42-0,54-0,59-0,63
Dividend per Share ------
Announcement Date 11/10/202103/10/202205/04/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2020 2021 2022 2023 2024
Net Debt1 -----
Net Cash position1 -20563,7351178
Leverage (Debt / EBITDA) -3,18x0,72x2,76x0,91x
Free Cash Flow1 --59,1-115-152-158
ROE (Net Profit / Equities) -----
Shareholders' equity1 -----
ROA (Net Profit / Asset) -----
Assets1 -----
Book Value Per Share -----
Cash Flow per Share -----
Capex -----
Capex / Sales -----
Announcement Date 07/09/202103/10/2022---
1 USD in Million
Estimates
Key data
Capitalization (USD) 109 094 477
Net sales (USD) 144 000
Number of employees 80
Sales / Employee (USD) 1 800
Free-Float 96,3%
Free-Float capitalization (USD) 105 028 904
Avg. Exchange 20 sessions (USD) 378 654
Average Daily Capital Traded 0,35%
EPS & Dividend